Evidence map›Paper›PMID 36815881›Full record

ArticleFrontiers in bioengineering and biotechnology2023

Jules Dichamp, Geraldine Cellière, Ahmed Ghallab, Reham Hassan, Noemie Boissier, Ute Hofmann, Joerg Reinders, Selahaddin Sezgin, Sebastian Zühlke, Jan G Hengstler and 1 more

Abstract read
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jules DichampGroup SIMBIOTX, INRIA Saclay-Île-de-France, Palaiseau, France.
Geraldine CellièreGroup SIMBIOTX, INRIA Saclay-Île-de-France, Palaiseau, France.
Ahmed GhallabLeibniz Research Centre for Working Environment and Human Factors, Technical University Dortmund, Dortmund, Germany.
Reham HassanLeibniz Research Centre for Working Environment and Human Factors, Technical University Dortmund, Dortmund, Germany.
Noemie BoissierGroup SIMBIOTX, INRIA Saclay-Île-de-France, Palaiseau, France.
Ute HofmannDr. Margarete Fischer-Bosch Institute of Clinical Pharmacology and University of Tübingen, Stuttgart, Germany.
Joerg ReindersLeibniz Research Centre for Working Environment and Human Factors, Technical University Dortmund, Dortmund, Germany.
Selahaddin SezginFaculty of Chemistry and Chemical Biology, TU Dortmund, Dortmund, Germany.
Sebastian ZühlkeCenter for Mass Spectrometry (CMS), Faculty of Chemistry and Chemical Biology, TU Dortmund University, Dortmund, Germany.
Jan G HengstlerLeibniz Research Centre for Working Environment and Human Factors, Technical University Dortmund, Dortmund, Germany.
Dirk DrasdoGroup SIMBIOTX, INRIA Saclay-Île-de-France, Palaiseau, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

acetaminophenAPAPdigital twindrug toxicityin vitro to in vivo extrapolationmetabolismmodelingmulti-scale

Identifiers

PMID36815881
PMCPMC9932319

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.